Cargando…

Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality

Antidepressant (AD)- emergent mood switch (AEMS) is a common complication of bipolar depression. This study aimed to investigate the prevalence and clinical correlates of subthreshold AEMS (i.e. not fulfilling DSM criteria for hypomanic episodes) in major depressive disorder (MDD) and, prognosticall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olgiati, Paolo, Serretti, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373846/ https://www.ncbi.nlm.nih.gov/pubmed/37351585 http://dx.doi.org/10.1097/YIC.0000000000000479

Ejemplares similares

Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder
por: Olgiati, Paolo, et al.
Publicado: (2023)

Influence of postpartum onset on the course of mood disorders
por: Serretti, Alessandro, et al.
Publicado: (2006)

Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorder
por: Olgiati, Paolo, et al.
Publicado: (2022)

Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorder
por: Olgiati, Paolo, et al.
Publicado: (2021)

Age or age of onset: which is the best criterion to classify late-life depression?
por: Olgiati, Paolo, et al.
Publicado: (2023)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

Neural network analysis in pharmacogenetics of mood disorders
por: Serretti, Alessandro, et al.
Publicado: (2004)

Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future
por: Fabbri, Chiara, et al.
Publicado: (2020)

Genetics of Late-Onset Alzheimer's Disease: Update from the Alzgene Database and Analysis of Shared Pathways
por: Olgiati, Paolo, et al.
Publicado: (2011)

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study
por: Schosser, Alexandra, et al.
Publicado: (2017)

Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II
por: Baldessarini, Ross J., et al.
Publicado: (2016)

No Effect of Serotoninergic Gene Variants on Response to Interpersonal Counseling and Antidepressants in Major Depression
por: Serretti, Alessandro, et al.
Publicado: (2013)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder
por: Dold, M., et al.
Publicado: (2018)

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
por: Fugger, Gernot, et al.
Publicado: (2022)

Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder
por: Tadić, André, et al.
Publicado: (2011)

Differences in the prevalence and clinical correlates of comorbid suicide attempts in patients with early- and late-onset major depressive disorder
por: Huang, Xiao, et al.
Publicado: (2023)

Polymorphisms of stress pathway genes and emergence of suicidal ideation at antidepressant treatment onset
por: Nobile, B., et al.
Publicado: (2020)

Anhedonia and Depressive Disorders
por: Serretti, Alessandro
Publicado: (2023)

A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
por: Han, Changsu, et al.
Publicado: (2018)

Temperament and Character in Euthymic Major Depressive Disorder Patients: The Effect of Previous Suicide Attempts and Psychotic Mood Episodes
por: Ekinci, Okan, et al.
Publicado: (2012)

Suicide in Adolescents with Mood Disorders
por: Shah, K., et al.
Publicado: (2022)

How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach
por: Fabbri, Chiara, et al.
Publicado: (2020)

Depression, suicidality and antidepressants: A coincidence?
por: Selvaraj, Vithyalakshmi, et al.
Publicado: (2010)

Frontal Alpha Asymmetry Correlates with Suicidal Behavior in Major Depressive Disorder
por: Park, Yeonsoo, et al.
Publicado: (2019)

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
por: Dold, Markus, et al.
Publicado: (2018)

Pharmacy and Medical Costs Associated With Switching Between Venlafaxine and SSRI Antidepressant Therapy for the Treatment of Major Depressive Disorder
por: Khandker, Rezaul K., et al.
Publicado: (2008)

Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment
por: Fabbri, Chiara, et al.
Publicado: (2020)

Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone
por: Kern, David M., et al.
Publicado: (2023)

Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
por: Han, Changsu, et al.
Publicado: (2020)

The Staging of Major Mood Disorders: Clinical and Neurobiological Correlates
por: Muneer, Ather, et al.
Publicado: (2018)

PS281. Lifetime suicidal ideation and attempt in community adults with full major depressive disorder versus only sustained depressed mood
por: Yoo, Hye Jin, et al.
Publicado: (2016)

Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants
por: Gibbons, Andrew Stuart, et al.
Publicado: (2015)

Assessment of lethality and its clinical correlates in suicide attempters with mood disorders
por: Chawla, Nishtha, et al.
Publicado: (2022)

The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants
por: Serretti, Alessandro
Publicado: (2018)

Pharmacogenetics of antidepressant response: An update
por: Drago, Antonio, et al.
Publicado: (2009)

Clinical Utility of Fluid Biomarker in Depressive Disorder
por: Serretti, Alessandro
Publicado: (2022)

ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder
por: Chang, Buru, et al.
Publicado: (2019)

Relationship Between Affective Temperaments and Suicide Risk in Patients With First-Onset Major Depressive Disorder
por: Yin, Lu, et al.
Publicado: (2022)

Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression
por: Fugger, Gernot, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8keddaa2fhq2kc5pt1krilom49